Trials that use: Exact / Clopper-Pearson binomial
New to this method? Read the tutorial →
1,265 results
- PPJIndependent statistical analysis of Piloting "Positive Peer Journaling" a Journaling Practice to Support Recovery From Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pre-market Study to Evaluate Safety and Performance of GreenBone Implant (Long Bone Study): Complete Statistical AnalysisIndependent statistical analysis of Pre-market Study to Evaluate Safety and Performance of GreenBone Implant (Long Bone Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PrE1003Independent statistical analysis of Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use: Complete Statistical AnalysisIndependent statistical analysis of Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02680145).
- Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: Complete Statistical AnalysisIndependent statistical analysis of Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01337297).
- PREHABIndependent statistical analysis of A Supervised Prehabilitation Program for Patients With Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05692323).
- PREMIERIndependent statistical analysis of Prospective Study on Embolization of Intracranial Aneurysms With Pipeline™ Embolization Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Pressure Guidewire System Multi-center, Prospective, Self-Control, Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04582877).
- PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): Complete Statistical AnalysisIndependent statistical analysis of PREVAIL-TA: Placement of Aortic Balloon Expandable Transcatheter Valves Trial (Europe): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01238835).
- PREVENTIndependent statistical analysis of Prazosin to Prevent COVID-19 (PREVENT-COVID Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04365257).
- PREVENTIndependent statistical analysis of Prehabilitation of Veterans With Exercise and Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04485611).
- PREVENTIndependent statistical analysis of Protocol-guided Rapid Evaluation of Veterans Experiencing New Transient Neurological Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02769338).
- Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03207386).
- Preventing Sickle Cell Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sickle Cell Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02373241).
- Previously Implanted Pudendal Nerve Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Previously Implanted Pudendal Nerve Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04473469).
- Priapism in Boys and Men With Sickle Cell Disease – Demographics, Characteristics and Prevalence: Complete Statistical AnalysisIndependent statistical analysis of Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRIDE-HTIndependent statistical analysis of PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRIMEIndependent statistical analysis of the PRIME phase 3 trial of panitumumab plus FOLFOX versus FOLFOX alone in metastatic colorectal cancer, including progression-free survival, overall survival, objective response, and statistical methodology.
- PRIMEIndependent statistical analysis of Prospective Research in Infants With Mild Encephalopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01747863).
- PRISMIndependent statistical analysis of Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRISMIndependent statistical analysis of Efficacy and Safety Study of I10E in Treatment of Patients With CIDP: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PRO 140 in Treatment-Experienced HIV-1 Subjects: Complete Statistical AnalysisIndependent statistical analysis of PRO 140 in Treatment-Experienced HIV-1 Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03902522).
- ProACTIndependent statistical analysis of ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Project_SuMIndependent statistical analysis of Providing Expanded Continuous Labor Support to Pregnant Women in New Mexico With Substance Use Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ProMRI Study of the Entovis Pacemaker System: Complete Statistical AnalysisIndependent statistical analysis of ProMRI Study of the Entovis Pacemaker System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01761162).
- Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00550290).
- Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202): Complete Statistical AnalysisIndependent statistical analysis of Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate: Complete Statistical AnalysisIndependent statistical analysis of Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Prostatic Urethral Lift in Subject With Acute Urinary Retention: Complete Statistical AnalysisIndependent statistical analysis of Prostatic Urethral Lift in Subject With Acute Urinary Retention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03194737).
- Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00592592).
- Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340495).
- Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: Complete Statistical AnalysisIndependent statistical analysis of Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01849822).
- Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: Complete Statistical AnalysisIndependent statistical analysis of Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02950467).
- PSMA PreRPIndependent statistical analysis of Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919111).
- PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176497).
- PSUNRISE – Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: Complete Statistical AnalysisIndependent statistical analysis of PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PULSED AFIndependent statistical analysis of Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04198701).
- PVPIndependent statistical analysis of A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- Qualitative Assessment of Implementing Routine Rapid HIV Testing: Complete Statistical AnalysisIndependent statistical analysis of Qualitative Assessment of Implementing Routine Rapid HIV Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680862).
- QUARTO_IIIIndependent statistical analysis of Quartet Lead and Resynchronization Therapy Options III (QUARTO_III): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02476201).
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: Complete Statistical AnalysisIndependent statistical analysis of Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: Complete Statistical AnalysisIndependent statistical analysis of RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Radial Reload Laparoscopic LAR Case Series: Complete Statistical AnalysisIndependent statistical analysis of Radial Reload Laparoscopic LAR Case Series: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01706822).